Parsons Capital Management Inc Acurx Pharmaceuticals, Inc. Transaction History
Parsons Capital Management Inc
- $1.8 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding ACXP
# of Institutions
27Shares Held
1.28MCall Options Held
9.3KPut Options Held
9.7K-
Vanguard Group Inc Valley Forge, PA529KShares$386,4240.0% of portfolio
-
Prospect Financial Services LLC Melville, NY329KShares$240,2250.15% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$106,9450.0% of portfolio
-
Morgan Stanley New York, NY46.2KShares$33,7260.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC44.8KShares$32,6890.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $8.44M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...